US equities
|
NVDA
$240.27
▲+0.57%
SPCX
$172.20
▲+0.65%
MU
$1,059.75
▼-0.40%
MRVL
$286.86
▲+5.75%
AMD
$654.44
▲+3.59%
INTC
$114.45
▼-1.50%
AVGO
$378.55
▲+4.42%
TSLA
$379.89
▲+0.31%
NVDA
$240.27
▲+0.57%
SPCX
$172.20
▲+0.65%
MU
$1,059.75
▼-0.40%
MRVL
$286.86
▲+5.75%
AMD
$654.44
▲+3.59%
INTC
$114.45
▼-1.50%
AVGO
$378.55
▲+4.42%
TSLA
$379.89
▲+0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Pliant Therapeutics, Inc. - Common Stock
(NQ:
PLRX
)
1.025
-0.005 (-0.49%)
Delayed Quote
Updated: 2:44 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pliant Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
↗
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
↗
November 24, 2021
Upgrades For Aegon NV (NYSE:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
↗
November 03, 2021
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE:
Via
Benzinga
Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump
↗
September 07, 2021
Midway through trading Tuesday, the Dow traded down 0.76% to 35,098.84 while the NASDAQ rose 0.09% to 15,376.87. The S&P also fell, dropping 0.33% to 4,520.38. The U.S. has...
Via
Benzinga
Topics
Stocks
Why Pliant Therapeutics Stock Is Surging Today
↗
September 07, 2021
A positive phase 2 clinical trial readout was a positive step in the right direction for this biotech start-up.
Via
The Motley Fool
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
↗
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
↗
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...
Via
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
↗
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
↗
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 07, 2021
Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...
Via
Benzinga
Pliant Stock Moves Higher On Positive Data From Pulmonary Fibrosis Trial
↗
September 07, 2021
Pliant Therapeutics Inc (NASDAQ: PLRX) stock is moving higher during the premarket session in reaction to interim results from a Phase 2a positron emission...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
↗
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
↗
September 05, 2021
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 03, 2021
Gainers Enveric Biosciences (NASDAQ:ENVB...
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
↗
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
August 20, 2021
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
↗
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
63 Biggest Movers From Friday
↗
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021
↗
April 20, 2021
Upgrades Compass Point upgraded the previous rating for Newtek Business Services Corp (NASDAQ:NEWT) from Neutral to Buy. For the fourth quarter, Newtek Business Services...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
